TORONTO, ON / ACCESSWIRE / December 9, 2019 / Murchison Minerals Ltd. ("Murchison" or the "Company") (TSXV: MUR) is pleased to announce it has acquired an additional 5,601 hectares (56.01 km2) of mineral claims (M Claim Block) located east of the existing Brabant Lake project in northern Saskatchewan (see Figure 1).

The M Claim Block covers twelve electromagnetic ("EM") conductors previously identified in an historic airborne geophysical survey completed in 1968. Figure 2 identifies these conductor traces which are presented over a regional airborne magnetic image, highlighting that some occurrences are coincident with magnetic high features, a criterion derived from the geophysical signature of the Brabant-McKenzie VMS deposit. The 1968 survey detected the Brabant-McKenzie deposit conductor as well as numerous other conductors detected by the modern VTEM airborne EM and magnetic surveys completed over the Brabant Lake project. This historical survey has also detected other EM conductors on lands already controlled by Murchison that do not have modern airborne EM coverage.

The area, including the M Claim Block, is dominantly underlain by garnetiferous biotite gneisses and highly-metamorphosed mafic volcanic rocks similar to those at the Brabant-McKenzie VMS deposit.

Murchison owns the Brabant-McKenzie VMS deposit, which remains open to expansion, and twelve high-priority targets scheduled to be drilled in Q1 / 2020. The recent addition of six new highly prospective claim blocks, covering about 107 km2 (Henry 1-5 and M Claim blocks), significantly enhances the Company's land holdings.

Qualifying Statement

The foregoing scientific and technical disclosures have been reviewed by Ehsan Salmabadi, P. Geo., and Martin St-Pierre, P. Geoph., qualified persons as defined by National Instrument 43-101. Mr. Salmabadi and Mr. St-Pierre are independent consultants to Murchison and the Brabant Lake project.

About the Brabant Lake Project

The Brabant Lake project is located 175 kilometres northeast of La Ronge, Saskatchewan and approximately three kilometres from the community of Brabant Lake. The area is accessed year‐round via provincial Highway 102 and is serviced by grid power. The project consists of one mining lease which hosts the Brabant‐McKenzie VMS deposit, and additional mineral claims totalling 430 km2 and extending over 57 kilometres of strike length over favourable geological horizons, multiple known mineralized showings, and identified geophysical conductors.

NI 43-101 Resources of the Brabant-McKenzie VMS Deposit

• Indicated – 2.1 million tonnes at 7.08% zinc, 0.69% copper, 0.49% lead, 39.60 g/t silver or 9.98% zinc equivalent

• Inferred – 7.6 million tonnes at 4.45% zinc, 0.57% copper, 0.19% lead, 18.40 g/t silver or 6.29% zinc equivalent

About Murchison Minerals Ltd. (TSXV: MUR)

Murchison is a Canadian‐based exploration company focused on the exploration and development of the 100% owned Brabant Lake zinc‐copper‐silver project in north‐central Saskatchewan. The Company also has a 100% interest in the HPM nickel‐copper‐cobalt project in Quebec. Murchison currently has 48.4 million shares issued and outstanding.

Additional information about Murchison and its exploration projects can be found on the Company's website at www.murchisonminerals.com. For further information, please contact:

Jean‐Charles (JC) Potvin, President and CEO
jcpotvin@murchisonminerals.com

Erik H Martin, CFO
Tel: (416) 350‐3776
info@murchisonminerals.com

Forward‐Looking Information

Certain information set forth in this news release may contain forward‐looking information that involves substantial known and unknown risks and uncertainties. This forward‐looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, the impact of general economic conditions, industry conditions, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward‐looking information. The parties undertake no obligation to update forward‐looking information except as otherwise may be required by applicable securities law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Murchison Minerals Ltd.

ReleaseID: 569530

SUDBURY, ON / ACCESSWIRE / December 9, 2019 / Northern Superior Resources (TSXV:SUP) ("Northern Superior" or the "Company") is pleased to announce that the Company has defined two new gold-bearing systems on its 100% owned Lac Superior gold property in Québec.

HIGHLIGHTS:

Épervier Gold System – the extension of the Renard gold trend from the IAMGOLD Corporation ("IAMGOLD")/Vanstar Mining Resources Inc. ("Vanstar"), Nelligan property; and
Roi System – a second system further to the west

Épervier Gold System:

Intersection of 1.54 g/t Au over 15.15m (including 10.80 g/t Au over 0.66m): compliments widths and grades reported from intersections associated with the Renard gold deposit, 5km northeast within the adjoining Nelligan gold property (see Vanstar PowerPoint presentation, May 2019);
Intersected ~750m strike length (system remains open) of gold-bearing material consisting of the same package of mineralized rocks described for, and believed to extend from, the Renard gold deposit (seeFigure 1): hydrothermally altered (sericite + silicic +/-fuchsite) and veined volcaniclastic and sedimentary packages, hosting disseminations and lenses of pyrite at up to 5 volume %);
A positive correlation has been noted between gold and similar pathfinder trace elements as observed at the neighbouring Nelligan Deposit (e.g., Molybdenum);
Intersected host volcaniclastic-metasedimentary assemblage is 50-100m wide; and
Extent of system is undefined: It is unknown whether the system is offset or folds onto itself (see Figure 1).

Dr. T.F. Morris, President and CEO states: "Defining a ~750m extension of the Renard gold trend onto the Lac Surprise property from a limited drill program is an excellent start. The system remains open over a significant area of the property allowing for the opportunity to intersect additional gold-bearing material with widths and gold grades similar to those associated with the Nelligan deposit. There is clearly justification for additional drilling to pursue this opportunity."

Roi Gold System:

The related structure defined by the geophysical data, indicates that this NNE trending structure clearly extends into the E-W trending Geurcherville Deformation Zone (GDZ), creating potential zones favorable to dilatation, more concentrated fluid flow and therefore opportunity for the precipitation of meaningful concentration of gold from solution;
Structure can be traced at least 6 km from the magnetic data (open along strike, both directions) and corresponds to a distinct, associated gold grain-in-till anomaly;
Intersected structure consists of ~50m of mineralized material comprised of a silicified, weakly brecciated, brittle, hematite-carbonate altered fault breccia; and
Wide value of anomalous gold values (including 0.12 g/t Au over 24.60m; Table 2) with elevated Te, S, Bi and Ag (up to 1.06 g/t Ag).

Dr. T.F. Morris, President and CEO further states: "Multiple, geophysical and gold grain defined targets to the north and south of the discovery hole (LCS-19-12) now warrant follow up drilling in the next phase of exploration on this exciting new gold-bearing structure."

Figure 1: Location, Épervier and Roi gold systems, Lac Surprise gold property

Table 1: Summary, Key Intersections, Épervier Gold System

Drill Hole

From (m)

To (m)

Width (m)

Au (g/t)

Incl. Au (g/t)

Width (m)

LCS-19-005

104.00

109.00

5.00

0.06

0.07

1.00

203.83

228.50

24.67

0.05

0.21

1.00

LCS-19-007

178.00

185.00

7.00

0.05

0.11

1.00

LCS-19-008

252.00

262.00

10.00

0.05

0.08

1.00

277.00

292.15

15.15

1.54

10.80

0.60

292.45

296.00

3.55

0.17

0.30

1.00

299.00

310.00

11.00

0.10

0.18

1.00

LCS-19-010

162.00

175.00

13.00

0.05

0.10

1.00

275.00

279.00

4.00

0.12

0.16

1.00

BP-17-04†

181.55

185.00

3.15

0.23

1.28

0.43

233.00

239.34

6.34

1.12

4.50

0.73

BP-17-05*

61.00

102.50

41.50

0.25

2.21

0.76

126.75

130.00

3.25

0.31

0.54

1.05

† Historic assay results (Kilbourne & Armstrong 2017, internal document)

* Historic assay results plus 2019 infill sampling

Table 2: Summary, Key Intersections, Roi Gold System

Drill Hole

From (m)

To (m)

Width (m)

Au (g/t)

Incl. Au (g/t)

Width (m)

LCS-19-012

74.00

79.30

5.30

0.06

0.12

1.00

108.00

132.60

24.60

0.12

0.28

1.00

About the Lac Surprise Property

The Lac Surprise Property is tied onto the northwest side of the Nelligan Gold Property. Vanstar describes the gold deposit on the Nelligan property as part of a "vast auriferous system offering a potential of multi-million gold ounces" (Vanstar PowerPoint presentation, May 2019). IAMGOLD and Vanstar, IAMGOLD's partner on the project, recently announced an initial 43-101 compliant mineral resource estimate of 3.2 million inferred ounces of gold for the Nelligan Gold Project (see IAMGOLD/Vanstar press releases, October 22, 2019).

Based upon the 2019 core drill program results as described in this press release, Northern Superior believes that this gold system extends west onto the Lac Surprise property, as defined (so far) by the Épervier Gold System.

The Épervier gold system coupled with the discovery of the Roi gold system and the various other gold showings and gold-bearing shear zones previously defined on the Lac Surprise property, makes this property yet another high value exploration asset 100% owned by Northern Superior Resources.

Qualified Person

Jonathan O'Callaghan P.Geo., is a Qualified Person ("QP") within the meaning of National Instrument 43-101. As the QP for the Lac Surprise property, Mr. O'Callaghan has reviewed, and approved information disclosed in this press release.

About Northern Superior Resources Inc.

The Lac Surprise gold property is one of four mineral properties that Northern Superior is currently exploring. The other three properties also represent regional scale exploration programs, 100% owned by Northern Superior. Exploration to date has identified:

numerous drill-ready targets for gold, copper and silver on the Ti-pa-kaa-haa-ning (TPK) property of northwestern Ontario;
a gold deposit (11.6 million tonnes, grade 1.7ppm Au 640,000 oz Au) and numerous opportunities on the Croteau Est property in west-central Québec; and
a variety of commodities on the Wapistan property, James Bay Lowlands, Québec.

Northern Superior is a reporting issuer in British Columbia, Alberta, Ontario and Québec, and trades on the TSX Venture Exchange under the symbol SUP, and the OTCQB Venture Market under the symbol NSUPF.

For further information please visit the Company's website at www.nsuperior.com or contact:

Thomas F. Morris P.Geo., PhD., FGAC
President and CEO
Tel: (705) 525 ‐0992
Fax: (705) 525 ‐7701
e‐mail: info@nsuperior.com

For further information please refer to the following Northern Superior news releases: January 27, 2014; March 9, 2017; March 9, 2017; January 29, 2019; February 6, 2019; July 9, 2019; August 7, 2019; September 10, 2019; available on the Company's website and SEDAR.

Cautionary Note Regarding Forward-Looking Statements

This Press Release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such actual results of current exploration programs, the general risks associated with the mining industry, the price of gold and other metals, currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to put undue reliance on such forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Northern Superior Resources Inc.

ReleaseID: 569456

HACKENSACK, NJ / ACCESSWIRE / December 9, 2019 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced it will report its financial and operational results for the second quarter ended October 31, 2019, on Monday, December 16, 2019, after market close.

The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST). To participate in the call, please call 844-369-8770 (domestic) or 862-298-0840 (international) ten minutes ahead of the call and give the verbal reference "Champions Oncology."

A replay of the call will be available by dialing 877-481-4010 and entering Passcode:56884, or by accessing the Investor tab of the company's website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology, Inc. is engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs. The Company's TumorGraft technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments, or TumorGrafts, in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The Company uses this technology in conjunction with related services to offer solutions primarily in Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas as well as through Champions' Personalized Oncology Solutions business. For more information, please visit www.championsoncology.com.

Investor Contacts:

David Miller
CFO
Champions Oncology, Inc
(551) 206-8104
dmiller@championsoncology.com

SOURCE: Champions Oncology, Inc.

ReleaseID: 569435

ATLANTA, GA / ACCESSWIRE / December 9, 2019 / Perma-Fix Environmental Services, Inc. ("Perma-Fix" or the "Company") (NASDAQ:PESI) recently hosted its 17th Nuclear Waste Management Forum 2019 from December 2-4, in Nashville, Tennessee with nearly 200 industry executives in attendance. The forum focused on radioactive waste and remediation challenges within the DOE complex along with new technologies and innovations in development to provide near-term solutions. The annual event provided industry leaders an opportunity to network with experts from a variety of U.S. and international waste generator sites, government officials, and other small and large businesses.

Featured speakers included Anne White, Former Assistant Energy Secretary for Environmental Management, and officials from the U.S. Department of Energy. One of the more popular events included a featured panel on Women in Nuclear.

The forum hosted a variety of speakers representing nuclear utility plants, international entities and US Department of Energy programs including Environmental Management, National Nuclear Security Administration and Office of Science. The 2019 forum panels consisted of: Department of Energy Programs Challenges and Initiatives; National Nuclear Security Administration Legacy Remediation Programs; New Market Offerings; Increased Value of Waste Technology Offerings; and Innovative Approaches to Meet Emerging Industry Challenges.

Through the two days of sessions, Perma-Fix introduced its latest technologies and applications regarding waste characterization, packaging, treatment, transportation, and disposition while sharing lessons learned that could improve safety and efficiency for their projects. Among topics discussed were Perma-Fix's most recent upgrades to its facilities to support client initiatives, as well as an introduction of the Perma-SortSM soil segregation process.

Mark Duff, President & CEO, stated, "This year's conference was a major success, as we provided a unique forum for Perma-Fix to strengthen existing relationships with clients and partners, while delivering a platform to review new developments in technologies and facilities to address the most complex waste management challenges in our industry. As Perma-Fix continues to grow and address new market challenges, this event serves as an ideal venue to discuss detailed customer issues and solutions, including technical considerations, as well as providing opportunities to team with other industry leaders and clients. This event and the positive feedback from the industry further illustrate our growing reputation as a leader in the nuclear waste industry, with unique treatment capabilities, a growing service business, and impeccable safety record. We are committed to providing our customers and partners unmatched value in the marketplace."

About Perma-Fix Environmental Services

Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the DOE, the DOD, and the commercial nuclear industry. The Company's nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates three nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities, nationwide.

Please visit us at http://www.perma-fix.com.

This press release contains "forward‑looking statements" which are based largely on the Company's expectations and are subject to various business risks and uncertainties, certain of which are beyond the Company's control. Forward-looking statements generally are identifiable by use of the words such as "believe," "expects," "intends," "anticipate," "plans to," "estimates," "projects," and similar expressions. Forward‑looking statements include, but are not limited to: upgrades to facilities to support client initiatives; and continues to grow and address new market challenges. These forward‑looking statements are intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. While the Company believes the expectations reflected in this news release are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this release, including, without limitation, future economic conditions; industry conditions; competitive pressures; our ability to apply and market our new technologies; the government or such other party to a contract granted to us fails to abide by or comply with the contract or to deliver waste as anticipated under the contract; inability to win bid projects; that Congress fails to provides continuing funding for the DOD's and DOE's remediation projects; inability to obtain new foreign and domestic remediation contracts; inability to meet financial covenants; and the "Risk Factors" discussed in, and the additional factors referred to under "Special Note Regarding Forward-Looking Statements" of, our 2018 Form 10-K and Forms 10-Q for quarters ended March 31, 2019, June 30, 2019 and September 30, 2019. The Company makes no commitment to disclose any revisions to forward‑looking statements, or any facts, events or circumstances after the date hereof that bear upon forward‑looking statements.

Please visit us on the World Wide Web at http://www.perma-fix.com.

Contacts:

David K. Waldman-US Investor Relations
Crescendo Communications, LLC
(212) 671-1021

Herbert Strauss-European Investor Relations
herbert@eu-ir.com
+43 316 296 316

SOURCE: Perma-Fix Environmental Services, Inc.

ReleaseID: 569426

NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Veriheal has taken the U.S. by storm as an innovative cannabis tech platform that discreetly helps connect prospective patients with licensed doctors who can approve them for their residing state's medical cannabis program. But the company's objectives don't immediately stop there. In an effort to break the stigma, Veriheal also strives to educate the public about cannabis through its blog and provides knowledge to those that are curious about medicating with cannabis. From cooking tips to current politics, Veriheal puts the people first and is eager to help encourage them on their path to healing. So, they are willing to take it to the next level.

Many people go out and get their medical cannabis cards but may struggle to figure out the next steps. Luckily, Veriheal has recently added a new personalized cannabis consult service that is available nationwide in all 50 states. This will give everyone the opportunity to evaluate whether or not cannabis is right for them because medical card certifications are strictly limited to populations where medicinal cannabis is legalized. The purpose of these personalized assessments is to provide those who are new or old to cannabis with a one-on-one discussion with an expert that can further target and refine their recommendations based on a patient's individual interests. These consultations cover things such as recommended terpene and cannabinoid profiles, offer guidance on due-diligence, as well as up to date information on state cannabis laws. The results are all exclusively tailored to the patient.

Cannabis has undoubtedly garnered world-wide interest as alternative medicine, but current laws and the stigma often keep many people from learning more about it or even attempting to consider it in their treatment plan. One of Veriheal's main goals is to reassure the public about cannabis and restore its reputation as a legitimate form of therapy. Furthermore, they want to make the information available to everyone. Imagine being able to discreetly connect with and receive quality medical cannabis advice from a licensed healthcare professional with just the click of a button.

Telemedicine is the wave of the future. Its convenience lets people take charge of their health from the comforts of their own home. More importantly, it's inclusive and the opportunity expands accessibility to everyone with internet access. Telemedicine gives all walks of life the chance to better themselves when the option may not have been previously available. For the demographic that is on-the-go whose schedules don't allow flexibility to those who are mentally or physically unable to travel, Veriheal has streamlined these demands and strives to assist where possible.

In addition to broadening the availability of options for others, Veriheal's new personalized consultations provide expert and qualified advice on cannabis. Many leading brands in the cannabis and CBD space already advocate consulting with a medical professional before using any cannabis-based products. This disclaimer is absolutely necessary. Cannabis therapy is not backed by solid authoritative research and there could be a potential concern for adverse reactions. This is especially true for patients who can't afford to experience a negative interaction with medications that they are already taking. Veriheal's network of doctors will thoroughly evaluate and help build a wellness plan accommodated specifically for each individual patient.

Personalized cannabis consults are a great avenue for people who want to know if cannabis is right for them, who might be confused about legalization, would like to know about which products are best for them, or need help formulating a regimen that best fits their lifestyle. These appointments are simply a conversation about how cannabis and CBD can impact the patient and their health. Afterward, patients will have the choice to pursue cannabis medication on their own accord with the information they were given or move forward and book a medical card consultation that will certify them for the medical cannabis program in their state if they haven't already. Either way, Veriheal has the information and it is ready for the taking whether cannabis is legal or not in each state. They encourage everyone to be prepared that way when opportunities come around, patients will have the knowledge to be able to properly navigate themselves in the name of their health. Those that might be curious about pursuing cannabis-based remedies should contact Veriheal to speak with one of their experts and discover if its the right choice for them.

About Veriheal

Veriheal is a healthcare technology company with a mission to provide personalized cannabis education and wellness to everyone around the world. The company does that by connecting patients and doctors online, through their platform, to provide recommendations for living a better life.

For more information about Veriheal visit: https://www.veriheal.com.

Media Contact Information:

Anthony Dutcher
info@veriheal.com
https://www.veriheal.com/contact-us/ and select the Press/Media option

SOURCE: Veriheal

ReleaseID: 569383

LOS ANGELES, CA and NEWARK, NJ / ACCESSWIRE / December 9, 2019 / IDW Media Holdings, Inc., (OTCPINK:IDWM), an integrated media company, today announced that Chris McGurk has joined the Company's Board of Directors. Mr. McGurk is the Chairman and CEO of Cinedigm (CIDM).

"I am delighted to welcome Chris McGurk to the Board of IDW Media. Chris is one of the truly innovative leaders in the film and television industries. His expertise will be invaluable as we further align IDW Media to develop IP for audiences globally," said Howard Jonas, IDW Media's Chairman and CEO.

Mr. McGurk has served as the Chairman and Chief Executive Officer of Cinedigm since 2011. Before joining Cinedigm, he founded Overture Films and served as its CEO and as CEO of Anchor Bay Entertainment, which distributed Overture Films' product to the home entertainment industry.

Previously, Mr. McGurk was Vice Chairman of the Board and Chief Operating Officer of Metro-Goldwyn-Mayer Inc. ("MGM"), and President and Chief Operating Officer of Universal Pictures. He has also held senior executive positions at The Walt Disney Studios including Studios CFO and President of The Walt Disney Motion Picture Group and PepsiCo Inc., including CFO of Pepsi-Cola East. Mr. McGurk has served as a director at several publicly-listed and private companies including Metro Goldwyn Mayer Inc., BRE Properties Inc., DIVX Inc. and DIC Entertainment.

"I have known Howard Jonas for over a decade and am looking forward to joining him on the IDW Media Board. We have a unique opportunity to build on the great work already being done by IDW Media's management and board to create a truly exceptional company," Mr. McGurk said.

Chris McGurk earned a Bachelor of Science degree in accounting from Syracuse University School of Management and a Master of Business Administration degree from the University of Chicago Graduate School of Business.

About IDW Media Holdings:

IDW Media Holdings, Inc. (OTCPINK: IDWM) is an integrated media company. IDW Media's businesses include IDW Publishing – a leading American publisher of comic books and graphic novels, IDW Entertainment – a producer and distributor of franchise content through television and other media, and CTM Media Group Inc., – one of North America's largest distributors of information for tourists and travelers.

Investor Contact:

Ezra Rosensaft, Chief Financial Officer
IDW Media Holdings
ezra@idwmh.com

SOURCE: IDW Media Holdings, Inc.

ReleaseID: 569373

TORONTO, ON / ACCESSWIRE / December 9, 2019 / California Gold Mining Inc. ("California Gold" or "CGM" or the "Company") (CSE: CGM) (OTC-QX: CFGMF) is pleased to provide the following updates regarding its operations:

The Company anticipates realizing its first-ever operating profit in Q1 2020;
Toll-extraction agreement with an industry-leading, North Carolina-based extraction and processing company has been executed;
Harvest, and post-harvest treatment of the high-CBD hemp crop from its 100%-owned Grove Road farm in Kendall County, Illinois has been successfully completed;
Additional high-CBD hemp biomass has been purchased from farmers in Virginia and North Carolina;
Processing of the Company's wholly owned hemp biomass into winterized and decarboxylated crude oil with 60 – 65% total cannabinoid content ("Crude Oil") has commenced;
The Company projects production of 2,200 – 2,500 litres of Crude Oil by year-end; current wholesale prices for Crude Oil range from US$900 to US$1,250 per litre;
CGM is finalizing a second toll-extraction agreement with an Arizona-based extraction company to produce distillate with 70 – 80% total cannabinoid content ("Distillate"); and
The Company projects production of 600 – 700 litres of Distillate in Q1 2020 in addition to its Crude Oil; current wholesale prices for Distillate range from US$2,600 to US$3,250 per litre.

Further details on each of the above items is set forth in this press release.

California Gold's President and CEO, Mr. Vishal Gupta stated, "We are delighted that despite our recent entry into the high-CBD hemp space and the prevalent industry-wide price compression, CGM is well-positioned to post a healthy operating profit in Q1 2020. The completion of our crop harvest in Illinois, and partnership with an industry-leading cannabinoid extraction company in North Carolina, are important operational milestones for the Company. Even more significant are the relationships that the Company has recently formed with several farming families in Virginia and North Carolina that have the potential to transform a one-time revenue-generation event resulting from the sale of cannabinoid-rich finished products extracted from our hemp biomass harvested in Illinois, into a continuous revenue stream due to the availability of several hundred thousand pounds of unsold, high-quality hemp biomass in these farming communities."

Toll-Extraction Services Secured

After investigating more than a dozen different extraction companies over the course of three months, CGM executed a toll-extraction agreement with a North Carolina-based company ("Extraction Partner") to produce finished cannabinoid-rich oils and isolates. CGM retained an industry-renowned expert in extraction technologies to conduct due diligence on its Extraction Partner, and the following boxes were checked:

(a) High-efficiency, ethanol- and heptane-based extraction technology;
(b) High-quality end products;
(c) Significant operating capacity to produce finished hemp-CBD products in bulk;
(d) Competitive pricing for toll-extraction;
(e) Willingness to schedule CGM's biomass extraction ahead of others; and
(f) Ability to create a variety of end-products as per CGM's specifications.

The toll-processing agreement was signed on October 24th, 2019.

Illinois Harvest & Post-Harvest Treatment

CGM completed the harvest of its hemp crop at the Grove Road farm in Illinois on October 25th, 2019. The Company also executed a contract for turn-key, post-harvest processing of the harvested crop in Illinois with a private, multi-faceted, hemp-CBD corporation that recently customized a 64,000 sq. ft. warehouse in Oglesby, Illinois for post-harvest treatment of its plants.

Post-harvest treatment involves air-drying of hemp plants to bring total moisture content under 10% by weight, and removal of stems, branches, and leaves. The remaining dried flower content is the "biomass" that is eventually used in the extraction process. The post-harvest treatment of CGM's crop was completed on November 27th, 2019 with total biomass yield of 11,117 lbs and an average CBD content of approximately 10% ("Illinois Biomass").

This yield is significantly lower than what we had projected at the beginning of the project, and can be directly attributed to the ‘one in 30 years' rainfall experienced in the US mid-West during the 2019 cultivation season. Despite this shortfall in yield, the Illinois Biomass is expected to produce an operating profit for CGM.

While CGM's Grove Road farm in Illinois was experiencing excessive rains this cultivation season, the weather patterns in Virginia and North Carolina were much more favourable to hemp cultivation. This is where the Company's management team found an opportunity to off-set the diminished yields in Illinois.

Identification & Purchase of Additional Biomass in Virginia & North Carolina

During the course of negotiating the toll-processing agreement with its new Extraction Partner, CGM's management team learned of dozens of farming families (the "Farmers") in southern Virginia and northern North Carolina cultivating high-CBD hemp crops in 2019. Preliminary discussions with these Farmers revealed that hundreds of thousands of pounds of hemp biomass are available for purchase at very reasonable terms.

An initial batch of 35,242 lbs of biomass ("Initial Batch") was purchased on November 27th, 2019. Approximately 65% of this Initial Batch has now been processed into Crude Oil. Processing of the remaining 35% is expected to be completed by year-end.

Total Crude Oil production from the Initial Batch is expected to be between 2,200 and 2,500 litres by year-end. Wholesale prices for Crude Oil are currently ranging between US$900 and US$1,250 per litre.

CGM's Board of Directors is currently evaluating the purchase of successive batches of biomass from the Farmers upon completing the sale of Crude Oil from the Initial Batch. At present time, there are several hundred thousand additional pounds of unsold, high-quality hemp biomass available for purchase by CGM.

Second Toll-Extraction Agreement & Off-Take Agreements Being Negotiated

The Company is currently negotiating a second toll-extraction agreement with an Arizona-based extraction company to produce high-margin Distillate.

The Company is also currently in discussions with several interested purchasers who have requested samples of its Crude Oil in order to conduct their own testing of the product before placing purchase orders. Management expects the Company to start generating revenue from the sale of its finished extraction products in January 2020.

As a result of the Company's current focus on the production of finished extraction products, and management's projections for relatively quick revenue realization from this endeavour, CGM's Board of Directors has decided to temporarily defer the Company's plans to construct a greenhouse for hemp seed propagation on its Grove Road farm in Illinois.

About California Gold Mining Inc.

California Gold Mining Inc. is focused on continued development of a high-quality gold resource on its 100%-owned Fremont property in Mariposa County, California. The Fremont property consists of an entirely private and patented land package totaling 3,351 acres of historically producing gold mines, with a state highway, PG&E electric substation and abundant water present on the property itself. The Fremont property lies within California's prolific Mother Lode Gold Belt that has produced over 50 million ounces of gold. The Company purchased the Fremont property in March 2013.

The Company is also in the process of establishing an outdoor, high-CBD industrial hemp biomass cultivation operation on the newly-acquired Grove Road Farm property in Kendall County, Illinois. The Company plans to use a portion of cash flow from its hemp biomass and hemp seed operations to continue development of its gold business, with minimal dilution for shareholders.

The Company's technical report in respect of the Fremont Property prepared pursuant to National Instrument 43-101 is available on SEDAR at www.sedar.com and on the Company's website at www.caligold.ca.

CAUTION REGARDING FORWARD-LOOKING INFORMATION

This news release of California Gold contains statements that constitute "forward-looking statements". Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause California Gold's actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements in this document include statements regarding (i) the amount of Crude Oil that will be produced by the Company by year-end; (ii) the fact that current wholesale prices for Crude Oil may change in the future, (iii) the Company's ability to execute a second extraction agreement, (iv) the Company's ability to negotiate off-take agreements, (v) the amount of Distillate that the Company will produce in Q1 2020, (vi) the fact that the current wholesale prices for Distillate may change in the future and (vii) the proposed purchase of successive batches of biomass from the Farmers . There can be no assurance that such statements will prove to be accurate. Actual results and future events could differ materially from those anticipated by such statements and could materially affect the Company's results of operations. Readers are cautioned not to place undue reliance on forward looking statements in this press release. California Gold does not undertake any obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change, unless otherwise required by law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact:
Vishal Gupta, President & CEO
Tel.: 647-977-9267 x333 | Website: www.caligold.ca

SOURCE: California Gold Mining Inc.

ReleaseID: 569526

TORONTO, ON / ACCESSWIRE / December 9, 2019 / StageZero Life Sciences, Limited (TSX:SZLS) (''StageZero'' or the ''Company''), a life sciences company specializing in blood-based biomarker tests for early cancer detection, announced today that it has expanded its multi-year licensing agreement with Oncore Pharma, Inc.

According to the Company, Oncore Pharma, in addition to commercializing ColonSentry under the exclusive 5-year licensing agreement, will now add BreastSentry and the Prostate Health Index to its offering. The initial agreement with Oncore Pharma for ColonSentry has the aim to deploy a total of 1,750,000 tests over the next 5 years. The addition of BreastSentry and Prostate Health Index will add significantly to this.

Under the terms of the agreement, Oncore Pharma and its partners will bear all costs of marketing and distributing the tests, as well as collection of the test samples and shipping to StageZero's laboratory in Richmond, Virginia. StageZero will receive a fixed fee for processing and reporting the tests. Additionally, StageZero has received 1 million common shares of Oncore Pharma and will receive a special royalty payment equal to 10% of Oncore's yearly profits.

"We created Oncore Pharma to focus specifically on research, development and commercialization of Oncology products and ColonSentry is exactly the type of diagnostic test the market needs and our customers demand," said Martin Verronneau, the President and CEO of Oncore Pharma Inc. "With the recent publication in Breast Cancer following the NCRI Cancer Conference of Glasgow, we have been asked to expand our offering with BreastSentry™ and the Prostate Health Index, to allow for screening of multiple cancers," further added Mr Verronneau.

"There is significant interest in being able to screen easily and routinely for multiple cancers, and our tests meet this need," said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences, Ltd. "Our combined ability to engage with patients, particularly in the early detection of cancers like colorectal, breast and prostate, are very topical in Europe and in demand. Oncore Pharma's experience in bringing products to market, coupled with their scientific knowledge, provides our company with a great advantage. BodyCheck NL, Oncore Pharma's partner in the Benelux countries, has indicated they will initiate testing during the first quarter of next year (2020)," added Mr. Howard-Tripp.

About StageZero Life Sciences

StageZero Life Sciences is dedicated to the early detection of cancer and multiple disease states through whole blood. Aristotle®, our next generation test, is a panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on our proven and proprietary Sentinel Principle Technology Platform which has been validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer, with further validation currently underway. In addition to building a pipeline of products for early cancer detection, the Company operates a CAP accredited and CLIA certified reference laboratory based in Richmond, Virginia that offers the ColonSentry® test as well as licensed biomarker tests for lung, breast and prostate cancers. To learn more visit www.stagezerolifesciences.com.

About Oncore Pharma

Oncore Pharma is a company specializing in the research, development and commercialization of Oncology products and services.

James R. Howard-Tripp
Chairman & CEO
jht@stagezerols.com
Tel: 1-855-420-7140 Ext. 1

Jerome Cliche
Financial Communication Advisor
LMCCOM@videotron.ca
Tel. (514) 815-8799

SOURCE: StageZero Life Sciences Ltd

ReleaseID: 569536

TORONTO, ON / ACCESSWIRE / December 9, 2019 / Fearless Films, Inc. (OTCQB:FERL) (The Company) announces that it has entered in a $5 million equity financing facility with Crown Bridge Partners, LLC. The funds will be used to develop the company's film assets by providing capital to complete film projects and to enable the company to participate as a partner with other production firms. The facility will also be used to provide capital for general corporate purposes. The facility is subject to closing conditions including regulatory approvals.

"We have a number of projects that are very promising and this funding will enhance our ability to move them forward in a timely manner. We believe that demand for quality entertainment content will continue as the advent of streaming media has created rising demand for entertainment properties." said Victor Altomare, CEO of the wholly-owned operating division, founder and creative lead for Fearless Films Inc. "We're very grateful to Crown Bridge Partners LLC for believing in our vision for the company" he added.

The Company's Business:

Fearless Films, Inc. is an independent full-service production company founded by award-winning actor, producer Victor Altomare. Along with company favorite; award-winning writer, director Goran Kalezic, Fearless produces top quality entertainment with an edge. The service scope specializes in short film and feature film production in addition to script writing, copywriting, fulfillment and distribution. Since its inception, Fearless Films has been on the map as a top independent producer winning accolades at most major film festivals and is known to have a keen eye for emerging talent.

Visit us at: www.fearlessent.com

Contacts:
Fearless Films, Inc.
Dennis dos Santos
President & CEO
416 665-7297
info.fearlessent@gmail.com

The Company trades on the OTCQB tier of the OTC market. Investors can find Real-time quotes and market Information for the Company on: http://www.otcmarkets.com/

Forward Looking Statements

Certain statements contained in the press release above are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations and statements of future economic performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to differ materially from what is currently anticipated. The Company cannot guarantee its future results, levels of activity, performance or achievements. The Company disclaims any obligation or intention to update any forward-looking statement.

SOURCE: Fearless Films, Inc.

ReleaseID: 569535

LOS ANGELES, CA / ACCESSWIRE / December 9, 2019 / InnerScope Hearing Technologies Inc. (OTCQB:INND) ("InnerScope") a manufacturer and Direct-to-Consumer ("DTC") distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products, ("Hearing Products") Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CBD Oil ("Hearing Health Products") (collectively "Hearing Product Portfolio"), today announced that it will be presenting at the 12th annual LD Micro Main Event on Wednesday, December 11th at 4:40 PM PST / 7:40 PM EST. Matthew Moore, CEO of InnerScope will be presenting and meeting with investors.

Moore will be joined by InnerScope's Chairman, Mark Moore for one-on-one meetings with institutional analysts and investors throughout the day.

"We are excited to present at the largest ever LD Micro Main Event Institutional Investor Conference said Matthew Moore, CEO of InnerScope Hearing Technologies. "InnerScope is proud to continued to deliver the message of the potential multiple health and cognitive risks related to untreated hearing loss. With an estimate of 42 million Americans that currently have untreated hearing loss, InnerScope, with its Hearing Product Portfolio and its innovative Direct-to-Consumer Hearing Aid Delivery Process gives easy access to hearing healthcare solutions."

"This year's Main Event is our largest event to date, with 275 companies set to present and meet with investors" stated Chris Lahiji, President of LD Micro. "Even though LD has emerged as one of the largest and most influential organizations in the space, our focus has never deviated from showcasing some of the more interesting businesses in the world to our ever-growing community. Investor interest in our events has also never been stronger, and that goes for our commitment to philanthropy as well."

The LD Micro Main Event will take place on December 10th-12th in Los Angeles, at the Luxe Sunset Bel Air Hotel, which will feature 275 companies, and will be attended by over 1,400 individuals.

View InnerScope's profile here: http://www.ldmicro.com/profile/INND

About InnerScope Hearing Technologies (OTCQB:INND)

InnerScope Hearing Technologies (OTCQB: INND) is a rapidly expanding consolidator of the hearing aid industry. Management is applying decades of profitable industry experience and technology to an antiquated and disjointed industry, unlocking scale and efficiency, which will serve all of InnerScope's stakeholders. Its direct-to-consumer model is revolutionizing the industry with its Walmart.com, Sears.com and Kmart.com relationship representing a paramount shift in the consumption of hearing aids by the hearing impaired.

In addition, InnerScope plans to continue to open, acquire, and operate a physical chain of audiological and retail hearing aid clinics. InnerScope's mission is to serve approximately 1.2 billion people around the globe that are suffering with 25db or greater hearing loss across the entire hearing impaired vertical from R&D and manufacturing through direct consumer sales and services. For more information, please visit: www.innd.com. For the Most Up-to-Date information about InnerScope Hearing Technologies (OTCQB: INND), please visit and follow our Official Twitter account @inndstock Page. https://twitter.com/inndstock

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:
Name: InnerScope Hearing Technologies, Inc.
Phone: 916-218-4100
Address: 2151 Professional Drive, 2nd Floor
Roseville, CA. 95661
Email: Info@innd.com

SOURCE: InnerScope Hearing Technologies, Inc. via LD Micro

ReleaseID: 569528